...BRCA2. Clinical trials have demonstrated successful treatment of homologous recombination-defective cancers with poly-ri...
...BRCA2 genes account for the major genetic predispositions to breast cancer. BRCA 1 and BRCA2 related breast cancers have...
...BRCA2 (30%) carriers, 40% had a cancer history. The majority of participants were nonHispanic White women (98%) of Ashke...
...BRCA2 mutations were expected according to the Myriad tables. However, 9 deleterious BRCA1 mutations (39.1%) were found;...
...BRCA2. Of 8 BRCA1 mutant patients 7 were classified as TN, while only 1 of 6 BRCA2 patients were TN (p < .001).,Patients...
...BRCA2. To address these limitations, we have pooled our updated datasets to provide robust estimates of the efficacy of ...
...BRCA2-8765delAG mutation (BRCA2 is also recognized as FANC-D1 gene). Assuming as significant difference in gene expressi...
...BRCA2 mutations (BRCA+) were selected from the Royal Marsden Hospital clinical genetics database and matched (1:2) with ...
...BRCA2 mutation carriers (45 yrs) and women tested negative for BRCA1 and BRCA2 mutations (46 yrs) as well as sporadic br...
...BRCA2 genes account for the majority of hereditary breast and ovarian cancer. Various risk assessment models are availab...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269